PT - JOURNAL ARTICLE AU - Amal R. Khanolkar AU - Nishi Chaturvedi AU - Valerie Kuan AU - Daniel Davis AU - Alun Hughes AU - Marcus Richards AU - David Bann AU - Praveetha Patalay TI - Socioeconomic inequalities in prevalence and development of multimorbidity across adulthood: findings from the MRC 1946 National Survey of Health & Development AID - 10.1101/2020.08.14.20174037 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.14.20174037 4099 - http://medrxiv.org/content/early/2020/08/16/2020.08.14.20174037.short 4100 - http://medrxiv.org/content/early/2020/08/16/2020.08.14.20174037.full AB - Objective To estimate multimorbidity trajectories and quantify socioeconomic inequalities based on both childhood and adulthood socioeconomic position in the risks and rates of adult multimorbidity accumulation.Design Prospective longitudinal national birth cohort study.Methods Participants from the 1946 National Survey of Health and Development (NSHD) who attended the age 36 assessment in 1982 and any one of the follow-up assessments at ages 43, 53, 63 & 69 (N=3,723, 51% males). Information on 18 health conditions was based on a combination of self-report, biomarkers, health records and prescribed medications. We estimated multimorbidity trajectories and delineated socioeconomic inequalities (based on childhood and adulthood social class and highest education) in multimorbidity at each age and in longitudinal trajectories.Results Multimorbidity increased with age from 0.7 conditions on average at 36 years to 3.7 at 69 years. Multimorbidity accumulation was non-linear, accelerating with age at the rate of 0.08 conditions/year (95% CI 0.07-0.09) at 36-43 years to 0.19 conditions/year (95% CI 0.18-0.20) at 63-69 years. At all ages, the most socio-economically disadvantaged had 1.2 to 1.4 times greater number of conditions on average compared to the most advantaged. The most socioeconomically disadvantaged by each socioeconomic indicator experienced an additional 0.39 conditions (childhood social class), 0.83 (adult social class) and 1.08 conditions (adult education) at age 69 years, independent of all other socioeconomic indicators. Adverse adulthood socioeconomic status was associated with more rapid accumulation of multimorbidity, resulting in 0.49 excess conditions in partly/unskilled compared to professional/intermediate individuals between 63-69 years. Disadvantaged childhood social class, independently of adult socio-economic position, was associated with accelerated multimorbidity trajectories from age 53 onwards.Conclusions Socioeconomically disadvantaged individuals have both earlier onset and more rapid accumulation of multimorbidity resulting in widening inequalities into old age, with independent contributions from both childhood and adulthood socio-economic position.Competing Interest StatementNC is remunerated for her membership of a data safety and monitoring committee of a trial sponsored by AstraZeneca. The remaining authors have no competing interests to declare.Funding StatementThis study was funded by the following grants: This work was supported by the UK Medical Research Council which provides core funding for the MRC Unit For Lifelong Health and Ageing at UCL and the MRC National Survey of Health and Development (MC_UU_00019/1, MC_UU_00019/3). Amal Khanolkar was supported by grant from the Wellcome Trust (ISSF3/H17RCO/NG1) and MRC (MC_UU_00019/3). DB is supported by the Economic and Social Research Council (grant number ES/M001660/1) and The Academy of Medical Sciences/Wellcome Trust (Springboard Health of the Public in 2040 award: HOP001/1025).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Written and/or informed consent was obtained from the study member at each stage of data collection. The study obtained ethical approval from Greater Manchester Local Research Ethics Committee and the Scotland Research Ethics committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are stored and held by the MRC Unit of Lifelong Health & Ageing, UCL. Requests for data can be made by contacting the unit directly.